Travere Therapeutics grants 32,000 RSUs to new employees
Travere Therapeutics granted 32,000 RSUs to six new employees on June 10, 2026, under Nasdaq Rule 5635(c)(4). The RSUs vest over four years, with 25% vesting annually, subject to continued service.
*this image is generated using AI for illustrative purposes only.
Travere Therapeutics, Inc. granted inducement equity awards covering an aggregate of 32,000 shares of its common stock to six new employees on June 10, 2026. The awards consist of inducement restricted stock units (RSUs), which were approved by the Compensation Committee of the Board of Directors. These grants were issued as material inducements for the individuals entering into employment with Travere Therapeutics in accordance with Nasdaq Listing Rule 5635(c)(4).
The RSUs are subject to the terms of Travere's 2018 Equity Incentive Plan but were granted outside of the plan. The vesting schedule is structured over four years, with 25% of the shares vesting on each anniversary of the grant date. Vesting is contingent upon the new employee's continued service relationship with Travere Therapeutics through the applicable vesting dates.
Grant Details
| Detail | Information |
|---|---|
| Grant Date | June 10, 2026 |
| Total Shares Granted | 32,000 |
| Recipients | 6 new employees |
| Vesting Period | 4 years |
| Vesting Schedule | 25% annually |
The grants were specifically authorized as an employment inducement under Nasdaq Listing Rule 5635(c)(4). This rule allows companies to issue equity awards to new employees as a material inducement to enter into employment, provided the awards are not granted under an existing equity plan unless specifically approved for such purposes.
What specific roles or expertise do these six new hires bring to Travere Therapeutics?
Will Travere Therapeutics continue to utilize inducement awards outside the 2018 Equity Incentive Plan for future hiring?
How might these grants impact the company's share dilution and overall compensation expenses over the next four years?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
